Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Omnicom Group Inc. (OMC) vs Stryker Corporation (SYK) Price & Performance

Omnicom Group Inc.Trade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Omnicom Group Inc. vs Stryker Corporation — how do they compare? Omnicom Group Inc. trades at $78.55 (market cap $22.26B), while Stryker Corporation trades at $276.2 (market cap $106.03B). The key difference: Stryker Corporation is far larger — about 4.8× Omnicom Group Inc.'s market cap, and Omnicom Group Inc. pays the higher dividend (3.94%). Which is the better fit depends on your goals.

OMCSYK
Market Cap
$22.26B$106.03B
Sector
MediaTechnology
52-Week High
$88.94$388.79
52-Week Low
$67.27$275.39
Enterprise Value
$30.33B$117.50B
Dividend Yield
3.94%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Omnicom Group Inc.

Omnicom Group (OMC) trades at $81.13, down 1.8% on the day, with a bearish technical outlook and mixed quarterly earnings performance. The company reported strong revenue growth to $17.27 billion in 2025 but posted a net loss of $54.5 million due to acquisition costs. Analyst consensus remains cautious with a 'Hold' rating despite a $96.50 price target representing 19% upside potential. Recent leadership transitions and media agency consolidation signal strategic repositioning amid challenging market conditions.

OMC presents a value opportunity with attractive valuation multiples (P/S: 0.91x, P/B: 2.3x) and a 4% dividend yield, but faces integration risks from the Interpublic acquisition and margin pressure. The stock's near-term trajectory depends on successful cost synergies and organic growth acceleration beyond current 6.1% levels. Debt levels have increased substantially post-acquisition, requiring careful monitoring of cash flow generation.

Stryker Corporation

Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.

The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Omnicom Group Inc.

Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.

Read more on OMC

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK